Cancer and fertility preservation: international recommendations from an expert meeting; Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis; Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies; Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic …; Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies; Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta …; ESHRE guideline: female fertility preservation; Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines; Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial; Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized …; Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective; Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting; Long-term safety of pregnancy following breast cancer according to estrogen receptor status; Triple-negative breast cancer: current perspective on the evolving therapeutic landscape; Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis; Targeted agents for cancer treatment during pregnancy; Follow-up strategies for women treated for early breast cancer.; Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: current state of the art; The five “Ws” for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs); Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
